| [1] |
ISO. Biological evaluation of medical devices-Part 5: tests for in vitro cytotoxicity [DB/OL]. 2009:
URL
|
| [2] |
Clark WR, Ferrari F, La Manna G, et al. Extracorporeal sorbent technologies: basic concepts and clinical application [J]. Contrib Nephrol, 2017, 190: 43-57.
|
| [3] |
Pomarè MD, Ankawi G, Lorenzin A, et al. Biocompatibility and cytotoxic evaluation of new sorbent cartridges for blood hemoperfusion [J]. Blood Purif, 2018, 46(3): 187-195.
|
| [4] |
Herrera-González AM, Caldera-Villalobos M, Peláez-Cid AA. Adsorption of textile dyes using an activated carbon and crosslinked polyvinyl phosphonic acid composite [J]. J Environ Manage, 2019, 234: 237-244.
|
| [5] |
Asai M, Kumakura S, Kikuchi M. Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients [J]. Ren Fail, 2019, 41(1): 47-56.
|
| [6] |
Ankawi G, Fan W, Pomarè MD, et al. A new series of sorbent devices for multiple clinical purposes: current evidence and future directions [J]. Blood Purif, 2019, 47(1-3): 94-100.
|
| [7] |
Huang Z, Wang SR, Yang ZL, et al. Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column [J]. Ther Apher Dial, 2013, 17(4): 454-461.
|
| [8] |
施钰琳. 合成树脂和碳化树脂血液灌流临床应用比较[J]. 中国中西医结合肾病杂志，2011, 12(8): 718-719.
|
| [9] |
Shariatinia Z. Carboxymethyl chitosan: properties and biomedical applications [J]. Int J Biol Macromol, 2018, 120(Pt B): 1406-1419.
|
| [10] |
Wang Y, Huang X, He C, et al. Design of carboxymethyl chitosan-based heparin-mimicking cross-linked beads for safe and efficient blood purification [J]. Int J Biol Macromol, 2018, 117: 392-400.
|
| [11] |
Nassar RA, Browne EP, Chen J, et al. Removing human immunodeficiency virus (HIV) from human blood using immobilized heparin [J]. Biotechnol Lett, 2012, 34(5): 853-856.
|
| [12] |
Ciejka J, Wolski K, Nowakowska M, et al. Biopolymeric nano/microspheres for selective and reversible adsorption of coronaviruses [J]. Mater Sci Eng C Mater Biol Appl, 2017, 76: 735-742.
|
| [13] |
王菲菲，王翔，熊延连，等. 新型内毒素特异吸附血液净化材料的制备与性能研究[J]. 生物医学工程学杂志，2013, 30(3): 635-640.
|
| [14] |
Shum HP, Yan WW, Chan TM. Extracorporeal blood purification for sepsis [J]. Hong Kong Med J, 2016, 22(5): 478-485.
|
| [15] |
Tani T, Shimizu T, Tani M, et al. Anti-endotoxin properties of polymyxin B-immobilized fibers [J]. Adv Exp Med Biol, 2019, 1145: 321-341.
|
| [16] |
Honore PM, Jacobs R, Joannes BO, et al. Newly designed CRRT membranes for sepsis and SIRS-a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review [J]. ASAIO J, 2013, 59(2): 99-106.
|
| [17] |
Ankawi G, Xie Y, Yang B, et al. What have we learned about the use of cytosorb adsorption columns? [J]. Blood Purif, 2019, 48(3): 196-202.
|
| [18] |
Poli EC, Rimmelé T, Schneider AG. Hemoadsorption with CytoSorb®[J]. Intensive Care Med, 2019, 45(2): 236-239.
|
| [19] |
Suzuki K, Shimazaki M, Kutsuki H. Beta2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis [J]. Ther Apher Dial, 2003, 7(1): 104-107.
|
| [20] |
那宇，柳慧敏. 高通量透析的研究进展[J/CD]. 中华肾病研究电子杂志，2015, 4(3): 10-13.
|
| [21] |
刘雪燕，刘晓君. 肾脏替代治疗滤器膜材料研究进展[J]. 中国血液净化，2018, 17(12): 847-849.
|
| [22] |
王庆，张斌. 血滤膜在脓毒症血液滤过应用和展望[J]. 中国卫生产业，2017, 14(27): 48-50.
|
| [23] |
姚英，章友康. β2微球蛋白与透析相关淀粉样变[J/CD]. 中华肾病研究电子杂志，2019, 8(3): 128-131.
|
| [24] |
Wernert V, Schäf O, Faure V, et al. Adsorption of the uremic toxin p-cresol onto hemodialysis membranes and microporous adsorbent zeolite silicalite [J]. J Biotechnol, 2006, 123(2): 164-173.
|
| [25] |
Aucella F, Gesuete A, Vigilante M, et al. Adsorption dialysis: from physical principles to clinical applications [J]. Blood Purif, 2013, 35(Suppl 2): 42-47.
|
| [26] |
Doi K, Iwagami M, Yoshida E, et al.Associations of polyethylenimine-coated AN69ST membrane in CRRT with the intensive care outcomes observations from a claims data base from Japan [J].Blood Purif, 2017, 44(3): 184-192.
|
| [27] |
Michikoshi J, Matsumoto S, Miyawaki H, et al. Evaluation of proteins and cells that adsorb to dialysis membranes used in continuous hemodiafiltration: comparison of AN69ST, polymethylmethacrylate, and polysulfone membranes [J]. Blood Purif, 2019, 48(4): 358-367.
|
| [28] |
Mark R. Marshall, 张凌，王敏敏，等. oXiris-内毒素吸附技术的临床应用[J]. 华西医学，2018(7): 797-800.
|
| [29] |
Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices [J]. Intensive Care Med Exp, 2018, 6(1): 12.
|
| [30] |
Cheah WK, Ishikawa K, Othman R, et al. Nanoporous biomaterials for uremic toxin adsorption in artificial kidney systems: a review [J]. J Biomed Mater Res B Appl Biomater, 2017, 105(5): 1232-1240.
|
| [31] |
Yarrarapu SNS, Sanghavi D. Molecular absorbent recirculating system [M]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021.
|
| [32] |
La Manna G, Donati G. Coupled plasma filtration adsorption: a multipurpose extracorporeal detoxification therapy [J]. Blood Purif, 2018, 46(3): 228-238.
|
| [33] |
McCrea K, Ward R, LaRosa SP. Removal of carbapenem-resistant enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion media [J]. PLoS One, 2014, 9(12): e114242.
|
| [34] |
Mattsby-Baltzer I, Bergstrom T, McCrea K, et al. Affinity apheresis for treatment of bacteremia caused by Staphylococcus aureus and/or methicillin-resistant S. aureus (MRSA) [J]. J Microbiol Biotechnol, 2011, 21(6): 659-664.
|
| [35] |
Kang JH, Super M, Yung CW, et al. An extracorporeal blood-cleansing device for sepsis therapy [J]. Nat Med, 2014, 20(10): 1211-1216.
|
| [36] |
Didar TF, Cartwright MJ, Rottman M, et al. Improved treatment of systemic blood infections using antibiotics with extracorporeal opsonin hemoadsorption [J]. Biomaterials, 2015, 67: 382-392.
|
| [37] |
Büttner S, Koch B, Dolnik O, et al. Extracorporeal virus elimination for the treatment of severe Ebola virus disease-first experience with lectin affinity plasmapheresis [J]. Blood Purif, 2014, 38(3-4): 286-291.
|